( TorontoVE:QPT )

News from OncoQuest Inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Oct 26, 2017, 12:47 ET OncoQuest Announces Collaboration with TESARO in Recurrent Ovarian Cancer Setting

Oregovomab to be Combined with ZEJULA® in a Proof-of-Concept Clinical Study EDMONTON, Oct. 26, 2017 /PRNewswire/ - OncoQuest Inc. ("OncoQuest"), a...


Jul 26, 2017, 09:30 ET First Patient Enrolled in OncoQuest's Phase 1/2 Study Combining Oregovomab with Hiltonol® in Recurrent Ovarian Cancer

Third Ongoing Study Examining Oregovomab in Combination with Other Drugs in Ovarian Cancer EDMONTON, July 26, 2017 /PRNewswire/ - OncoQuest Inc....


Jun 27, 2017, 09:47 ET OncoQuest Appoints Senior Biotech Investment Banker Hany Awadalla as Senior Vice President and Chief Financial Officer

EDMONTON, June 27, 2017 /PRNewswire/ - OncoQuest Inc. ("OncoQuest"), a privately held, cancer immunotherapy company, today announced the...


May 24, 2017, 23:53 ET OncoQuest presenta los resultados clínicos internos de fase II de Oregovomab para el tratamiento de primera línea del cáncer de ovario en el congreso anual de la American Society of Clinical Oncology (ASCO)

OncoQuest Inc. ('OncoQuest'), una compañía biofarmacéutica de propiedad privada centrada en el desarrollo y comercialización de productos...


May 24, 2017, 09:30 ET OncoQuest to Present Oregovomab Phase II Interim Clinical Results for Front Line Treatment of Ovarian Cancer at the American Society of Clinical Oncology (ASCO) Annual Meeting

EDMONTON, May 24, 2017 /PRNewswire/ - OncoQuest Inc. ("OncoQuest"), a privately held, biopharmaceutical company focused on the development and...